WCN26-3301 GLUCOCORTICOID DOSE AT DISCHARGE AND THE RISK OF INFECTIOUS COMPLICATIONS AND REHOSPITALIZATION IN RENAL DISEASES

20260 citationsJournal Articlegold Open Access

Authors

Kensei Yahata · Osaka Red Cross Hospital

Koichi Seta · Kyoto Medical Center

Keisuke Osaki · Kobe City Medical Center General Hospital

Akihiro Yoshimoto · Kobe City Medical Center General Hospital

Chiharu Kinoshita

Kaichi Kaneko · Kyoto University

Motoko Yanagita · Kyoto University

Abstract

Conclusion:The study will provide important data on the effectiveness of daratumumab either alone or in combination with ASCT in the treatment of both kidney and hematological conditions on various MGRS diseases.I have potential conflict of interest to disclose.Grant from Janssen-Cilag to conduct the study.I did not use generative AI and AI-assisted technologies in the writing process.

Topics & Keywords

Sarcoidosis and Beryllium Toxicity Research Neutrophil, Myeloperoxidase and Oxidative Mechanisms Renal Diseases and Glomerulopathies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Kidney International Reports

Volume 11, Issue 4, pp. 105730-105730

DOI: 10.1016/j.ekir.2026.105730

Field-Weighted Citation Impact: 0.00